Therefore, we studied sensitivity of metastatic cancer cells to TRAIL and demonstrated the differential TRAIL responsiveness of two pairs of primary (PC3 and KM12) and metastatic (PC3-MM2 and KM12L4A) cells. The gene discussed is TNFSF10; the disease is cancer.